跳至主要内容
临床试验/IRCT20140519017756N39
IRCT20140519017756N39已完成3 期

Comparison of the effects of levetiracetam, sodium valproate, and nortriptyline on migraine headaches control in migraine patients

Birjand University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Presence of migraine headaches (headache attacks over 3 attacks per month; each attack with an interval of more than 48 hours of relief from other attacks)
  • Age from 18 to 65 years
  • Non-use of other anti-migraine drugs since at least one month ago
  • No allergy to levetiracetam, sodium valproate, and nortriptyline or their compounds
  • Absence of acute migraine resistant to treatment
  • Not having severe mental disorders
  • Absence of neurodegenerative disorders
  • No malignancy
  • Absence of pain disorders
  • No severe infection
  • Informed consent for participation

排除标准

  • Pregnant or breast-feeding women
  • Irregular consumption of medications
  • Suffering from severe drug side-effects during the course of the study, which may change treatment regimen
  • Treatment-resistant acute migraine
  • Severe psychiatric disorders
  • Drug or alcohol dependence
  • Renal dysfunction
  • Excessive use of acute migraine drugs

研究者

相似试验